[PROVOCATING FACTORS IN SYSTEMIC LUPUS ERYTHEMATOSUS (WITH REFERENCE TO THERAPEUTIC AGENTS)].
D000927:Anticonvulsants; D000995:Antitubercular Agents; D001327:Autoimmune Diseases; D004342:Drug Hypersensitivity; D004358:Drug Therapy; D006046:Gold; D006634:Histamine H1 Antagonists; D006827:Hydantoins; D006830:Hydralazine; D008180:Lupus Erythematosus, Systemic; D008628:Mercury; D008779:Methylthiouracil; D010635:Phenolphthaleins; D010653:Phenylbutazone; D011803:Quinine; D013256:Steroids; D013449:Sulfonamides; D014116:Toxicology
D000927:Anticonvulsants; D000995:Antitubercular Agents; D006634:Histamine H1 Antagonists; D006827:Hydantoins; D010635:Phenolphthaleins; D013256:Steroids; D013449:Sulfonamides; D006830:Hydralazine; D006046:Gold; D011803:Quinine; D008628:Mercury; D010653:Phenylbutazone; D008779:Methylthiouracil
ANTICONVULSANTS; ANTIHISTAMINICS; ANTITUBERCULAR AGENTS; AUTOIMMUNE DISEASES; DRUG HYPERSENSITIVITY; DRUG THERAPY; GOLD; HYDANTOINS; HYDRALAZINE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MERCURY; METHYLTHIOURACIL; PHENOLPHTHALEINS; PHENYLBUTAZONE; QUININE; STEROIDS; SULFONAMIDES; TOXICOLOGIC REPORT
PROVOZIERENDE FAKTOREN DES SYSTEMATISCHEN LUPUS ERYTHEMATODES. (MIT  BERUECKSICHTIGUNG DER HEILMITTEL)